Monitoring of patients treated with lithium for bipolar disorder: an international survey
| Autor: | Nederlof, M., Heerdink, E.R., Egberts, A.C.G., Wilting, I., Stoker, L.J., Hoekstra, R., Kupka, R.W., Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology |
|---|---|
| Přispěvatelé: | Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology, Psychiatry, APH - Mental Health |
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
leukocyte count
glomerulus filtration rate Lithium (medication) creatinine blood level Remote patient monitoring patient monitoring urinalysis cholesterol blood level thyrotropin thyroxine blood level 0302 clinical medicine aspartate aminotransferase Health care calcium blood level psychiatrist resident 030212 general & internal medicine glucose kidney function medical society Survey sodium bipolar disorder bilirubin blood level potassium lcsh:QP351-495 creatinine article blood pressure waist circumference health survey very low density lipoprotein Psychiatry and Mental health lithium high density lipoprotein liver function nurse practitioner albumin blood level Thyroid function bilirubin triacylglycerol medicine.drug Pregnancy test medicine.medical_specialty sodium blood level Monitoring Bipolar disorder alanine aminotransferase maintenance therapy urea electrocardiogram Lithium Therapeutic drug monitoring lcsh:RC321-571 03 medical and health sciences urea blood level medicine parathyroid hormone human Medical prescription lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry albumin Biological Psychiatry thyroxine potassium blood level prescription calcium business.industry thyroid function Research practice guideline questionnaire parathyroid hormone blood level pregnancy test lithium blood level medicine.disease triacylglycerol blood level body mass 030227 psychiatry cell differentiation pulse rate glucose blood level thyrotropin blood level lcsh:Neurophysiology and neuropsychology general practitioner Emergency medicine high density lipoprotein cholesterol level Liver function business low density lipoprotein aspartate aminotransferase blood level clinical protocol alanine aminotransferase blood level low density lipoprotein cholesterol level |
| Zdroj: | International Journal of Bipolar Disorders, Vol 6, Iss 1, Pp 1-9 (2018) International Journal of Bipolar Disorders International journal of bipolar disorders, 6(1). Springer Open International Journal of Bipolar Disorders, 6(1). SpringerOpen International Journal of Bipolar Disorders, 6(1):12. Springer Open Nederlof, M, Heerdink, E R, Egberts, A C G, Wilting, I, Stoker, L J, Hoekstra, R & Kupka, R W 2018, ' Monitoring of patients treated with lithium for bipolar disorder: an international survey ', International Journal of Bipolar Disorders, vol. 6, no. 1, 12 . https://doi.org/10.1186/s40345-018-0120-1 |
| ISSN: | 2194-7511 |
| DOI: | 10.1186/s40345-018-0120-1 |
| Popis: | Background Adequate monitoring of patients using lithium is needed for optimal dosing and for early identification of patients with (potential) ADEs. The objective was to internationally assess how health care professionals monitor patients treated with lithium for bipolar disorder. Methods Using networks of various professional organizations, an anonymous online survey was conducted among health care professionals prescribing lithium. Target lithium serum levels and frequency of monitoring was assessed together with monitoring of physical and laboratory parameters. Reasons to and not to monitor and use of guidelines and institutional protocols, and local monitoring systems were investigated. Results The survey was completed by 117 health care professionals incorporating responses from twenty-four countries. All prescribers reported to monitor lithium serum levels on a regular basis, with varying target ranges. Almost all (> 97%) monitored thyroid and renal function before start and during maintenance treatment. Reported monitoring of other laboratory and physical parameters was variable. The majority of respondents (74%) used guidelines or institutional protocols for monitoring. In general, the prescriber was responsible for monitoring, had to request every monitoring parameter separately and only a minority of patients was automatically invited. Conclusions Lithium serum levels, renal and thyroid function were monitored by (almost) all physicians. However, there was considerable variation in other monitoring parameters. Our results help to understand why prescribers of lithium monitor patients and what their main reasons are not to monitor patients using lithium. Electronic supplementary material The online version of this article (10.1186/s40345-018-0120-1) contains supplementary material, which is available to authorized users. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |